<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Giant cell <z:mp ids='MP_0001856'>myocarditis</z:mp> (GCM) usually presents as <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001644'>dilated cardiomyopathy</z:hpo> that does not improve with guideline-based treatments </plain></SENT>
<SENT sid="1" pm="."><plain><z:hpo ids='HP_0004756'>Ventricular tachycardia</z:hpo> and <z:hpo ids='HP_0001678'>heart block</z:hpo> occur in a substantial number of patients </plain></SENT>
<SENT sid="2" pm="."><plain>Diagnosis by endomyocardial biopsy can allow for the addition of immunosuppressive therapy and timely use of mechanical circulatory support when indicated </plain></SENT>
<SENT sid="3" pm="."><plain>Recent studies suggest that the <z:hpo ids='HP_0004308'>ventricular arrhythmias</z:hpo> in GCM may be mediated by a cytokine-induced change in desmosomal protein expression </plain></SENT>
<SENT sid="4" pm="."><plain>Genomic and proteomic studies suggest that the regulation of inflammatory pathways differs in GCM from lymphocytic <z:mp ids='MP_0001856'>myocarditis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Transplantation remains an effective therapy despite a 20-25% risk of GCM recurrence in the allograft </plain></SENT>
<SENT sid="6" pm="."><plain>Recurrence in the native heart occurs up to 8Â years after initial diagnosis </plain></SENT>
<SENT sid="7" pm="."><plain>The long-term management of GCM patients, who initially recover, is not known and highlights the need for continuing multicenter collaborative clinical investigations </plain></SENT>
</text></document>